Skip to main content
. 2015 Oct 19;6(39):41638–41649. doi: 10.18632/oncotarget.5873

Figure 6. miR-1 inhibits the growth of implanted breast tumors in vivo.

Figure 6

The relative levels of miR-1 expression in the MCF-7/miR-1mimic, MCF-7/miR-1inhibitor or control MCF-7/miR-1NC CSCs were determined by quantitative RT-PCR A. The development and growth of implanted CSC-related tumors were monitored at the indicated time points post inoculation B. At the end of this experiment (on day 26 post inoculation), the relative levels of miR-1 expression in the different groups of dissected tumors were determined C. Data are expressed as the mean ± SD of each group of mice (n = 8 per group). *p < 0.05; **p < 0.01; ***p < 0.001 vs. the tumors induced by the MCF-7/miR-1NC CSCs.